Which of the following is a common treatment recommendation for COPD management?

Beta-agonist inhalers are a common treatment recommendation for the management of Chronic Obstructive Pulmonary Disease (COPD) due to their effectiveness in dilating the airways and improving airflow. These medications work by relaxing the muscles around the airways, which can help alleviate symptoms such as shortness of breath, wheezing, and coughing. They are typically used both for immediate relief during acute exacerbations (short-acting beta-agonists) and for ongoing management of the condition (long-acting beta-agonists).

In contrast, while hydration is important for overall health, it is not a primary treatment for COPD. Continuous oxygen therapy is indicated primarily for patients with significant hypoxemia rather than as a common treatment for all COPD patients. Long-term corticosteroids can be part of a treatment plan, but they are usually reserved for patients with frequent exacerbations and can have significant side effects; thus, they are not considered a first-line treatment for most COPD patients.